Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 28, 2020 17:32 ET | Source: Rigrodsky & Long, P.A.

Rigrodsky & Long, P.A. Reminds Investors of Investigation of Cellular Biomedicine Group, Inc. Buyout

WILMINGTON, Del., Dec. 28, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Cellular Biomedicine Group, Inc. (“CBMG”) (NASDAQ GS: CBMG) regarding possible...
November 03, 2020 13:15 ET | Source: Rigrodsky & Long, P.A.

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of BSTC, CBMG, CIT, and STND Buyouts

WILMINGTON, Del., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: BioSpecifics Technologies Corp. (NASDAQ GS: BSTC) regarding possible breaches of...
October 19, 2020 15:14 ET | Source: Rigrodsky & Long, P.A.

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of MYOK, CBMG, CIT, and STND Mergers

WILMINGTON, Del., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: MyoKardia, Inc. (NASDAQ GS: MYOK) regarding possible breaches of fiduciary...
October 14, 2020 13:14 ET | Source: Rigrodsky & Long, P.A.

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of EIDX, VRTU, CBMG, and CGIX Mergers

WILMINGTON, Del., Oct. 14, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Eidos Therapeutics, Inc. (NASDAQ GS: EIDX) regarding possible breaches of...
September 22, 2020 15:00 ET | Source: Rigrodsky & Long, P.A.

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of IMMU, VRTU, RST, and CBMG Buyouts

WILMINGTON, Del., Sept. 22, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Immunomedics, Inc. (NASDAQ GS: IMMU) regarding possible breaches of fiduciary...
September 02, 2020 20:00 ET | Source: Rigrodsky & Long, P.A.

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of PRNB, CBMG, PFNX, and VAR Buyouts

WILMINGTON, Del., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Principia Biopharma Inc. (NASDAQ GS: PRNB) regarding possible breaches of...
August 12, 2020 16:38 ET | Source: Rigrodsky & Long, P.A.

CELLULAR BIOMEDICINE GROUP, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout

WILMINGTON, Del., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Cellular Biomedicine Group, Inc. (“CBMG”) (NASDAQ GS: CBMG) regarding possible...
May 09, 2016 16:01 ET | Source: Cellular Biomedicine Group Inc.

Cellular Biomedicine Group Reports First Quarter 2016 Financial Results and Provides Business Highlights

– Reported Positive Clinical Data from Phase IIb trial of ReJoin® haMPC therapy– Expanded Stem Cell Platform with the Launch of New Allogeneic Clinical Trial– Closed Strategic Investment of $43.13...
May 07, 2015 08:30 ET | Source: Hagens Berman Sobol Shapiro LLP

Hagens Berman Alerts Investors in Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) of June 22nd Lead Plaintiff Deadline

SAN FRANCISCO, May 7, 2015 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, advises investors of the June 22, 2015 lead plaintiff deadline in a class action...
March 17, 2014 13:28 ET | Source: Cellular Biomedicine Group Inc.

Cellular Biomedicine Group Launches Development Program for Asthma Stem Cell Therapy

PALO ALTO, Calif., March 17, 2014 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (OTCQB:CBMG), a biomedicine firm engaged in the development of new treatments for degenerative and cancerous...